[Criteria for the selection of sulfonamides for the treatment of rodent malaria (Plasmodium vinckei)].
D000818:Animals; D001696:Biomechanical Phenomena; D005260:Female; D008288:Malaria / Q000188:drug therapy* / Q000662:veterinary; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010080:Oxazoles / Q000627:therapeutic use; D010961:Plasmodium / Q000187:drug effects*; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012376:Rodent Diseases / Q000188:drug therapy*; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013414:Sulfaguanidine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D013426:Sulfaphenazole / Q000627:therapeutic use; D013432:Sulfathiazoles / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D013890:Thiourea / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D010080:Oxazoles; D011725:Pyridines; D011743:Pyrimidines; D013424:Sulfanilamides; D013432:Sulfathiazoles; D013449:Sulfonamides; D013426:Sulfaphenazole; D013414:Sulfaguanidine; D013412:Sulfadimethoxine; D014295:Trimethoprim; D013890:Thiourea; D013420:Sulfamethoxazole
Kriterien für die auswahl von sulfonamiden zur Behandlung der Nagetiermalaria (Plasmodium vinckei.